Director Jill M. Quigley filed a Form 3 initial statement of beneficial ownership with the SEC on November 12, 2026, reporting her status as a newly reporting person at Filana Therapeutics, Inc. as of November 8, 2026.

Key Highlights

  • Reporting person: Jill M. Quigley, identified as a Director of Filana Therapeutics, Inc.
  • Triggering event date: November 8, 2026, listed as the date of event requiring the statement.
  • No securities held: The filing states "No securities are beneficially owned" in both Table I (non-derivative) and Table II (derivative securities).
  • Issuer and trading symbol: Filana Therapeutics, Inc., trading on NASDAQ:FLNA.
  • Signed by power of attorney: The form was signed by Eric J. Schoen pursuant to a Power of Attorney (Exhibit 24).

Quigley Reports No Beneficial Ownership Upon Joining Filana Therapeutics Board

According to the filing, Jill M. Quigley submitted a Form 3 initial statement of beneficial ownership to the SEC on November 12, 2026. The event requiring the statement occurred on November 8, 2026, which the filing identifies as the date Quigley became subject to Section 16(a) reporting obligations in connection with her role as a Director of Filana Therapeutics, Inc. (NASDAQ:FLNA).

The filing reports no holdings in either Table I, covering non-derivative securities, or Table II, covering derivative securities such as options, warrants, or convertible instruments. The filing states explicitly: "No securities are beneficially owned." Neither direct nor indirect ownership of any class of Filana Therapeutics securities is reported.

The form was filed by one reporting person and was signed by Eric J. Schoen acting by Power of Attorney, as referenced in Exhibit 24 attached to the filing. Quigley's address is listed as 6801 N Capital of Texas Hwy, Building 1, Suite 300, Austin, Texas 78731.

What Was Disclosed

Jill M. Quigley, a Director at Filana Therapeutics, Inc., filed an initial beneficial ownership statement reporting zero direct or indirect holdings in any class of the company's securities as of November 8, 2026.